Results 111 to 120 of about 26,835 (181)

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic Cancer. [PDF]

J Immunother Precis Oncol
Khawaja MR, Jameson G, Cridebring D, Shannon P, Han H, Moore J, Von Hoff D, Posner RG, Hlavacek WS, Kolch W, Kholodenko BN, Rukhlenko OS, Roe DJ, Wertheim BC, Borazanci E.   +14 more
europepmc   +1 more source

Superior efficacy of vemurafenib combined with iodine-131 for lymph node metastatic BRAF-mutant thyroid cancer: a long-term survival analysis. [PDF]

Am J Transl Res
Wang S, Zhang B, Da X, Xu J.
europepmc   +1 more source

The Emerging Melanoma Management: Historical Perspective to Future Directions. [PDF]

Cancers (Basel)
Hui SY, Jain R, Haass NK, Weninger W, Tikoo S, Guo D.   +5 more
europepmc   +1 more source

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication <i>in vitro</i> and <i>in vivo</i>. [PDF]

NAR Mol Med
Ravlo E, Ianevski A, Wolska W, Schjølberg JO, Cámara-Quílez M, Nordli IEO, Sæther IB, Lysvand H, Oksenych V, Vähä-Koskela M, Vainionpää S, Seppänen H, Smura T, Vauhkonen H, Odai R, Stoyanova A, Galabov SA, Galabov AS, Plevka P, Nekoua MP, Hober D, Bjørås M, Kainov DE.   +22 more
europepmc   +1 more source

Assessment of pharmacodynamic interactions of two-drug combinations of five selected cytostatics in an in vitro model of human melanoma: an isobolographic analysis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Wróblewska-Łuczka P, Góralczyk A, Łuszczki JJ.   +2 more
europepmc   +1 more source

TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities. [PDF]

J Proteome Res
Guo S, Qi T, Wang Y.
europepmc   +1 more source

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R). [PDF]

Hemasphere
De Carolis L, Capponi M, Bernardelli A, Visentin A, D'Elia GM, Ferrero S, Cimminiello M, Romeo A, Pocali B, Morino L, Sanna A, Annibali O, Ricci F, Falcinelli F, Mancini A, Angotzi F, Frustaci AM, Maschio N, Stelitano C, Gozzetti A, Moia R, Nicolosi M, Trappolini S, Leotta V, Pulsoni A, Foà R, Visco C, Murru R, Olivieri J, Trentin L, Falini B, Tiacci E.   +31 more
europepmc   +1 more source

α-terpineol induces apoptosis in melanoma cells and its underlying mechanism. [PDF]

Sci Rep
Liu W, Xiao Y, Zan X, Qi J, Ma T, Long Q, Wu B, Cao Y.   +7 more
europepmc   +1 more source

The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1. [PDF]

PLoS Biol
Mao F, Wu S, Allison DB, He D, Kong Y, Li C, Li Z, Zhang Y, Wang X, Zhang Q, Wang C, Liu X.   +11 more
europepmc   +1 more source

Maintenance Low-Dose BRAF Inhibition and Rituximab in Relapsed Hairy Cell Leukemia: A Therapeutic Alternative. [PDF]

Cureus
Patel A, Koilpillai S, Nguyen C, Baidas S.   +3 more
europepmc   +1 more source